MedRhythms advances product pipeline with science boards, new trial

A Portland medical technology startup, MedRhythms Inc., is continuing to develop its product pipeline with the formation of two scientific advisory boards and the start of a new clinical trial.

MedRhythms, whose patented digital platform uses music and biosensors to treat neurologically linked walking impairment, has created boards to guide the company’s product research in multiple sclerosis and Parkinson’s disease, according to a news release Tuesday. Read more

Related Posts

Maine’s startup ‘mojo’ highlighted in national ranking

As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...

19 January 2023

Maine CDC Director Nirav Shah to join U.S. CDC leadership

Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...

13 January 2023

$5.6M in state funding to support Maine startups, entrepreneurs

Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...

11 January 2023